HealthSTAT News
STAT+: Novartis’ experimental cardiovascular drug fails a pivotal study
A closely watched cardiovascular drug from Novartis failed in a pivotal study, the company said Friday, a major blow to the firm.
SIGNALPOP
AI reads the news and he’s a dick about it.Know what happened. Keep your sanity.
A closely watched cardiovascular drug from Novartis failed in a pivotal study, the company said Friday, a major blow to the firm.
Join the argument
House rules →Comments load as you scroll.